Clinical characteristics of classic Paroxysmal Nocturnal Hemoglobinuria (PNH) in pediatric patients: a comparison with classic PNH in adults. An international PNH registry study
Clinical characteristics of classic Paroxysmal Nocturnal Hemoglobinuria (PNH) in pediatric patients: a comparison with classic PNH in adults. An international PNH registry study
[version 1; not peer reviewed]Corresponding author A Urbano-Ispizua, and co-authors H Schrezenmeier, P Muus, G Socie, RA Brodsky, M Bessler, WF Rosse, Y Kanakura and P Hillmen are all on the advisory committee for Alexion Pharmaceuticals. Co-author P Muus is also on the advisory committee for Amgen, Celgene and Novartis. Co-author P Maciejewski has received research funding from Celgene and Eisai and is also a consultant fro Alexion Pharmaceuticals. Coauthor G Socie has received honoraria from Alexion Pharmaceuticals. Co-author M Bessler is on the speakers bureau for the National Organization for Rare Diseases. Co-author WF Rosse is a consultant for Alexion Pharmaceuticals. G Khursigara and CL Bedrosian are employees of Alexion Pharmaceuticals. Co-author P Hillmen is a consultant and has received honoraria and research funding from Alexion Pharmaceuticals.
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
All commenters must hold a formal affiliation as per our Policies. The information that you give us will be displayed next to your comment.
User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the User Comment Terms and Conditions. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.
Use of this website is subject to the F1000 Research Limited (F1000) General Terms and Conditions.
Submission of user comments to this website is subject to additional Terms and Conditions. By clicking "I accept the User Comment Terms and Conditions" before you submit your first comment, you agree to be bound by these conditions every time you submit a comment.
Terms relating to user comments